… Epithelial-to-mesenchymal transition (EMT) mechanism is responsible for metastasis and …
in mediating drug resistance of cancer cells. On the other hand, paclitaxel (PTX) and docetaxel …

… assessing the 10-year risk of distant recurrence in stage I or II … role in mediating both de
novo and acquired resistance to … Along these lines, TNBC resistance to docetaxel reflects the …

… This transition from epithelial to mesenchymal cells is … of inhibiting EMT-mediated
resistance to chemotherapy agents. … with the development of resistance or recurrence, multiple …

… increase the chance of tumor recurrence and resistance, calling … , there remains an elevated
risk of tumor recurrence and death … in relation to docetaxel-mediated inhibition of EMT. …

… ) acts as an epithelial-to-mesenchymal transition (EMT)-… Ezh2 could overcome docetaxel
resistance in PCa cells, by … for treatment failure and CSC-mediated clinical relapse [236]. In …

… the inhibition of EMT-mediated resistance displayed by tumor … It is worth mentioning that
CP and docetaxel (DOX) can be … as a vital reason for the recurrence of cancer. Prior studies …

… a high mortality rate threat. Tumor recurrence and metastasis due to treatment resistance are
… The epithelial–mesenchymal transition (EMT) is essential for tumor drug resistance. EMT …

… the PI3K activator IGF-1 at the same time. These data … to mediate EMT and Dox resistance.
Similarly, in vivo experiments showed that CNTN-1 silencing significantly increased docetaxel-…

… of these genes was mediated by EMT program activation (89). … resistance than completed
EMT cells, we selected docetaxel-… on tumor recurrence, metastasis, and drug resistance, which …

… indicating a high risk for distant tumor recurrence within the … breast cancer while inducing
docetaxel resistance in prostate … an important role in mediating cisplatin resistance in ovarian …